BTI
AUPH icon

Blue Trust Inc’s Aurinia Pharmaceuticals AUPH Stock Holding History

Blue Trust Inc’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2K Sell
690
-1,431
-67% -$20.9K ﹤0.01% 1837
2025
Q4 		$33.8K Sell
2,121
-4,455
-68% -$63.2K ﹤0.01% 1491
2025
Q3 		$72.7K Hold
6,576
– – ﹤0.01% 1221
2025
Q2 		$55.7K Sell
6,576
-603
-8% -$4.83K ﹤0.01% 1412
2025
Q1 		$57.7K Buy
7,179
+802
+13% +$6.5K ﹤0.01% 1266
2024
Q4 		$57.3K Buy
6,377
+6,174
+3,041% +$50.4K ﹤0.01% 1230
2024
Q3 		$1.16K Buy
+203
New +$1.26K ﹤0.01% 2681
2024
Q1 		– Sell
-55
Closed – – 2193
2023
Q4 		$0 Buy
+55
New +$453 ﹤0.01% 2480
2023
Q1 		– Sell
-27
Closed – – 2297
2022
Q4 		$0 Buy
+27
New +$157 ﹤0.01% 2224

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return